Literature DB >> 10025481

Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study.

I Kato1, P Toniolo, K L Koenig, A Kahn, M Schymura, A Zeleniuch-Jacquotte.   

Abstract

The authors compared the relative effectiveness of two distinct follow-up designs in prospective cohort studies--the active approach, based on direct contact with study subjects, and the passive approach, based on record linkages with population-based cancer registries--utilizing available information from the New York University Women's Health Study (WHS) and the New York State Cancer Registry (NYSCR). The analyses were limited to breast cancer cases identified during the period 1985-1992, for which follow-up was considered reasonably complete by both the WHS and the NYSCR. Among 12,947 cohort members who reported a New York State address, 303 pathologically confirmed cases were identified through active follow-up and 284 through record linkage. Sixty-three percent of cancers were identified by both sources, 21% by the WHS only, and 16% by the NYSCR only. The agreement was appreciably better for invasive cancers. The percentage of cases identified only by the NYSCR was increased among subjects whose active follow-up was incomplete, as well as among nonwhites, obese patients, and parous patients. This suggests that relying on either type of follow-up alone may introduce certain biases in evaluating risk factors for breast cancer. Combining both approaches appears to be a better strategy in prospective cohort studies.

Entities:  

Mesh:

Year:  1999        PMID: 10025481     DOI: 10.1093/oxfordjournals.aje.a009823

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.

Authors:  Yian Gu; Roy E Shore; Alan A Arslan; Karen L Koenig; Mengling Liu; Sherif Ibrahim; Anna E Lokshin; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

2.  Validity of self reported diagnoses of cancer in a major Spanish prospective cohort study.

Authors:  C Navarro; M D Chirlaque; M J Tormo; D Pérez-Flores; M Rodríguez-Barranco; A Sánchez-Villegas; A Agudo; G Pera; P Amiano; M Dorronsoro; N Larrañaga; J R Quirós; E Ardanaz; A Barricarte; C Martínez; M J Sánchez; A Berenguer; C A González
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

3.  Consumption of Lake Ontario sport fish and the incidence of colorectal cancer in the New York State Angler Cohort Study (NYSACS).

Authors:  Catherine L Callahan; John E Vena; Joseph Green; Mya Swanson; Lina Mu; Matthew R Bonner
Journal:  Environ Res       Date:  2016-12-30       Impact factor: 6.498

4.  DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.

Authors:  Jennifer D Brooks; Paul Cairns; Roy E Shore; Catherine B Klein; Isaac Wirgin; Yelena Afanasyeva; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol       Date:  2010-12       Impact factor: 2.984

5.  Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Authors:  Alan A Arslan; Roy E Shore; Yelena Afanasyeva; Karen L Koenig; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

6.  Identifying Local Hot Spots of Pediatric Chronic Diseases Using Emergency Department Surveillance.

Authors:  David C Lee; Stella S Yi; Hiu-Fai Fong; Jessica K Athens; Joseph E Ravenell; Mary Ann Sevick; Stephen P Wall; Brian Elbel
Journal:  Acad Pediatr       Date:  2017-04       Impact factor: 3.107

7.  Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.

Authors:  Tess V Clendenen; Karen L Koenig; Roy E Shore; Mortimer Levitz; Alan A Arslan; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

8.  Premenopausal serum androgens and breast cancer risk: a nested case-control study.

Authors:  Anne Zeleniuch-Jacquotte; Yelena Afanasyeva; Rudolf Kaaks; Sabina Rinaldi; Stephanie Scarmo; Mengling Liu; Alan A Arslan; Paolo Toniolo; Roy E Shore; Karen L Koenig
Journal:  Breast Cancer Res       Date:  2012-02-16       Impact factor: 6.466

9.  Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Authors:  Stephanie Scarmo; Yelena Afanasyeva; Per Lenner; Karen L Koenig; Ronald L Horst; Tess V Clendenen; Alan A Arslan; Yu Chen; Göran Hallmans; Eva Lundin; Sabina Rinaldi; Paolo Toniolo; Roy E Shore; Anne Zeleniuch-Jacquotte
Journal:  Breast Cancer Res       Date:  2013-02-26       Impact factor: 6.466

10.  Circulating enterolactone and risk of breast cancer: a prospective study in New York.

Authors:  A Zeleniuch-Jacquotte; H Adlercreutz; R E Shore; K L Koenig; I Kato; A A Arslan; P Toniolo
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.